Join Dr. Drew Moghanaki and Dr. Daniel Low from UCLA for a webinar to discuss the latest innovation from ViewRay - MRIdian A3i. Drs. Moghanaki and Low will discuss their experiences working on #MRIdian and ViewRay's own Brett Sloman will review features of the new A3i system, including collaborative workflow, automated contouring, tissue tracking, beam gating.
Vice Chair, Medical Physics Department of Radiation Oncology
Dr. Low is the Vice-Chair of Medical Physics in the Department of Radiation Oncology at the University of California at Los Angeles. Before joining UCLA in 2010, he was a professor and Director of Medical Physics in the Department of Radiation Oncology at Washington University. He earned his PhD in Physics in 1988 from Indiana University and was a postdoctoral fellow for two years in radiation therapy physics at MD Anderson Cancer Center. He is a Fellow of the American Association of Physicists in Medicine and is certified by the American Board of Radiology in Radiation Therapy Physics. He has been principal investigator on 5 National Institutes of Health R01 grants and has published more than 200 peer-reviewed manuscripts.
Dr. Moghanaki is a Professor and Chief of Thoracic Oncology at the UCLA Department of Radiation Oncology. He holds a joint appointment at the Greater Los Angeles Veterans Affairs Medical Center where he directs patient care and research for Veterans with lung cancer. He leads several national lung cancer initiatives in the VA including the VA Partnership to Increase Access to Lung Screening (VA-PALS) and the phase III VA Lung Cancer Surgery or Stereotactic Radiotherapy (VALOR) randomized clinical trial. He has been a member, advisor, and chair of multiple committees for national organizations and advocacy groups that includes the American Cancer Society, American Society of Clinical Oncology, American Society of Radiation Oncology, Radiosurgery Society, Veterans Health Administration, Lungevity Foundation, GO2 Foundation for Lung Cancer, and the International Association for the Study of Lung Cancer.